CA2455805C - Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques - Google Patents

Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques Download PDF

Info

Publication number
CA2455805C
CA2455805C CA2455805A CA2455805A CA2455805C CA 2455805 C CA2455805 C CA 2455805C CA 2455805 A CA2455805 A CA 2455805A CA 2455805 A CA2455805 A CA 2455805A CA 2455805 C CA2455805 C CA 2455805C
Authority
CA
Canada
Prior art keywords
lysine
protein
glycated
diabetic
fructose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2455805A
Other languages
English (en)
Other versions
CA2455805A1 (fr
Inventor
Truman R. Brown
Francis Kappler
Benjamin Szwergold
Sundeep Lal
Bangying Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fox Chase Cancer Center
Original Assignee
Fox Chase Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/794,433 external-priority patent/US6004958A/en
Application filed by Fox Chase Cancer Center filed Critical Fox Chase Cancer Center
Publication of CA2455805A1 publication Critical patent/CA2455805A1/fr
Application granted granted Critical
Publication of CA2455805C publication Critical patent/CA2455805C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2455805A 1997-02-05 1998-02-05 Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques Expired - Fee Related CA2455805C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/794,433 US6004958A (en) 1997-02-05 1997-02-05 Compounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetic's risk of developing complications and determining the efficacy of therapeutic intervention
US08/794,433 1997-02-05
CA002279428A CA2279428C (fr) 1997-02-05 1998-02-05 Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002279428A Division CA2279428C (fr) 1997-02-05 1998-02-05 Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques

Publications (2)

Publication Number Publication Date
CA2455805A1 CA2455805A1 (fr) 1998-08-06
CA2455805C true CA2455805C (fr) 2011-05-10

Family

ID=32094412

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2455805A Expired - Fee Related CA2455805C (fr) 1997-02-05 1998-02-05 Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques

Country Status (1)

Country Link
CA (1) CA2455805C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2664606B1 (fr) * 2012-04-25 2016-09-14 Ueno Fine Chemicals Industry, Ltd. Inhibiteur de la production de produits terminaux de glycation avancée

Also Published As

Publication number Publication date
CA2455805A1 (fr) 1998-08-06

Similar Documents

Publication Publication Date Title
CA2279428C (fr) Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques
US8431527B2 (en) Methods for alleviating deleterious effects of 3-deoxyglucosone
EP1115389A1 (fr) Fructosamine-oxydase: antagonistes et inhibiteurs
AU773401B2 (en) Compounds and their therapeutic use with diabetic complications
EP1085885B1 (fr) Procede permettant d'evaluer le risque du diabetique connaissant un etat pathologique associe aux diabetes
CA2455805C (fr) Composes et procedes concernant l'utilisation d'agents therapeutiques dans la prevention de complications diabetiques
US8138227B2 (en) Method for inhibiting or reversing non-enzymatic glycation
Krooth et al. Effect of 6-azauracil, and of certain structurally similar compounds, on three pyridoxal-phosphate requiring enzymes involved in neurotransmitter metabolism
WILSON et al. Investigation of the 5-hydroxylation of thiabendazole in rat liver microsomal preparations
CA2344690C (fr) Fructosamine-oxydase: antagonistes et inhibiteurs
Nyström On endothelial function in type 2 diabetic patients with coronary artery disease
Pirola Structure and Mechanism of Action of 5-aminolevulinate Synthase
NZ539272A (en) Using an antagonist or an inhibitor of Fructosamine oxidase to reduce minimising the effects of macrovascular and microvascular damage in a diabetic patient

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130205